Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Raymond A. Kempf"'
Autor:
John A. Thompson, Vernon K. Sondak, Megan Othus, Mark J. Porter, William E. Carson, Antoni Ribas, Lawrence E. Flaherty, Raymond A. Kempf, Jeffrey A. Sosman, Joseph M. Unger, Ralph J. Tuthill
Publikováno v:
Cancer immunology research, vol 2, iss 10
Associations between HLA class I antigen expression and the efficacy of a melanoma vaccine (Melacine; Corixa Corp.) were initially described in stage IV melanoma. Similar associations were observed in S9035, a phase III adjuvant trial evaluating Mela
Autor:
Stanley P. Balcerzak, Mark M. Zalupski, James R. Ryan, Fred Koppitch, Sandra R. Wolman, Raymond A. Kempf, Anwar N. Mohamed
Publikováno v:
Cancer Genetics and Cytogenetics. 99:45-53
We performed cytogenetic analysis and determined DNA content by flow cytometry (FCM) on freshly disaggregated tumor biopsies from 45 patients with soft tissue sarcomas (STG). Cytogenetically aberrant clones characterized 30 (67%) tumors, with the rem
Autor:
Parakrama Chandrasoma, Tillman M. Moore, Andy Sherrod, M F Quinn, Michael J. Pentecost, Charles P. Schwinn, Lawrence R. Menendez, Walter Wolf, Franco M. Muggia, Mary L. Stewart, Susan Groshen, M. D. Sapozink, Raymond A. Kempf, Wilbur Melbye, Lowell E. Irwin
Publikováno v:
Cancer. 68:738-743
Preoperative therapy has been tested as part of limb salvage therapy for localized bone and soft tissue sarcoma of the extremities. The activity of cisplatin (CDDP) by intraarterial (IA) infusion was evaluated in 40 cases of which 36 were evaluable f
Autor:
Michael K. Samson, Kenneth J. Kopecky, D. D. Von Hoff, Raymond A. Kempf, Franco M. Muggia, William S. Fletcher, Julie A. Kish
Publikováno v:
Investigational New Drugs. 9:105-108
Twenty-seven evaluable patients with advanced malignant melanoma received fludarabine phosphate in a daily x 5 injection. Initial dosing was based on the presence of previous radiation therapy. There was no response seen in these patients despite app
Autor:
P.Y. Liu, Jeffrey A. Sosman, Lawrence E. Flaherty, Min S. Park, Joseph M. Unger, John A. Thompson, Paul I. Terasaki, Raymond A. Kempf, Vernon K. Sondak
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(8)
PURPOSE: An association between expression of ≥ two of five HLA class I antigens (HLA-A2, HLA-A28, HLA-B44, HLA-B45, and HLA-C3; collectively called M5) and response to an allogeneic melanoma vaccine (Melacine; Corixa Corporation, Seattle, WA) has
Autor:
Raymond A. Kempf
Publikováno v:
Concepts, Mechanisms, and New Targets for Chemotherapy ISBN: 9781461358299
Skin cancers account for over 750,000 new cases of cancer per year, the majority of which are basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) [1]. Most of these cancers are easily treated and cured via a primary resection by a surgeo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99b66e100e69bd2a66a5bffc5a12ff49
https://doi.org/10.1007/978-1-4615-2007-8_7
https://doi.org/10.1007/978-1-4615-2007-8_7
Autor:
William Harel, Grace E. Dean, June Kan-Mitchell, Raymond A. Kempf, William D. Boswell, Eddie Hu, Lucy Stevenson, Malcolm S. Mitchell
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 8(5)
Twenty-five patients with metastatic melanoma were treated with a therapeutic vaccine ("theraccine") consisting of allogeneic melanoma lysates and a novel adjuvant, DETOX (Ribi ImmunoChem Research, Inc, Hamilton, MT). Each patient received 200 antige
Autor:
L. Flaherty, Joseph M. Unger, John F. Thompson, Jeffrey A. Sosman, P. Y. Liu, Vernon K. Sondak, Raymond A. Kempf, Ralph J. Tuthill
Publikováno v:
Journal of Clinical Oncology. 22:7501-7501
7501 Background: SWOG-9035 compared 2 years of an allogeneic melanoma lysate (Melacine™) to observation in patients (pts) with stage II melanoma 1.5–4.0 mm thick. We also analyzed the effects of expression of certain HLA antigens (≥2 of HLA-A2,
Publikováno v:
Clinical Orthopaedics and Related Research. 254:294
A 19-year-old man with telangiectatic osteosarcoma of the left proximal femur was started on a course of neoadjuvant chemotherapy consisting of intraarterial administration of cis-platinum. Within 72 hours of receiving the first intraarterial dose, t
Autor:
Raymond A. Kempf, Malcolm S. Mitchell, June Kan-Mitchell, Ashraf Imam, Robert L. Modlin, Clive R. Taylor
Publikováno v:
Journal of Investigative Dermatology. 86(2):145-148
Human monoclonal antibodies were generated by fusing a nonsecretory variant of murine mycloma cells with lymphocytes obtained from the lymph nodes of patients with metastatic cutaneous malignant melanoma. Two human IgG monoclonal antibodies, designat